Business1 hour ago
Naughty 😇•30%
Post-Covid Profit Surge: Investment Returns Decline Rapidly
Post-Covid, companies see profits rise but investment returns weaken. A recent study reveals that existing asset profitability doesn't guarantee attractive new investments, impacting marginal profitability.
⚖️ AI Verdict
"Looks like profits are thriving, but investments are playing hard to get!"
📢 Share Intel:
File ID: #379870Original Source: Times Of India ↗
🤖 SINS Investigator
Ask about this Intel File
🕵️♂️
File Opened for Analysis
Ask me anything about the event, its implications, or who is responsible for the SINS!
Deepen Investigation
Related Intelligence Files
Business33 minutes ago
ITAT Jaipur Ruling: Section 87A Rebate on STCG for AY 2024-25
The ITAT Jaipur ruling confirms taxpayers can claim Section 87A rebate on short-term capital gains for AY 2024-25. Despite CPC's denial during processing, the law does not prohibit this rebate. This decision offers significant relief to eligible taxpayers navigating tax regulations.
View File→
Business33 minutes ago
Rashi Peripherals Stock Drops 10% After Director Resignation
Rashi Peripherals faces a 10% stock drop following Anil Khandelwal's resignation over governance concerns. This exit echoes Atanu Chakraborty's recent departure from HDFC Bank, highlighting ongoing issues in corporate governance. Despite the turmoil, Rashi Peripherals has denied any lapses in their operations, aiming to reassure investors amidst the uncertainty.
View File→
Business33 minutes ago
Mumbai Auto Drivers Learn Marathi to Improve Ride Acceptance
Mumbai auto drivers are now learning Marathi to comply with a new state rule aimed at improving passenger experiences. The initiative includes training centers and a helpline for drivers, ensuring they can communicate effectively. However, some drivers are using basic phrases to refuse rides, leading to passenger frustration. The government hopes this will enhance ride acceptance and reduce excuses from drivers.
View File→
Business33 minutes ago
Guardant Health Hit with $245M Judgment for Patent Infringement
Guardant Health faces a $245 million judgment for cancer patent infringement. The ruling by a federal judge involves TwinStrand Biosciences and the University of Washington. Guardant will pay an upfront fee and ongoing royalties until March 2033, but plans to appeal the decision, asserting confidence in its case.
View File→